Cited 0 times in
Occurrence and Genotypic Distributions of Plasmid-Mediated AmpC β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae in korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 송, 원근 | - |
dc.contributor.author | 김, 재석 | - |
dc.contributor.author | 김, 미나 | - |
dc.contributor.author | 김, 의종 | - |
dc.contributor.author | 박, 연준 | - |
dc.contributor.author | 용, 동은 | - |
dc.contributor.author | 이, 경원 | - |
dc.contributor.author | 이, 위교 | - |
dc.contributor.author | 장, 석훈 | - |
dc.contributor.author | 이, 규만 | - |
dc.date.accessioned | 2011-12-20T05:05:54Z | - |
dc.date.available | 2011-12-20T05:05:54Z | - |
dc.date.issued | 2002 | - |
dc.identifier.issn | 2234-3806 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/4928 | - |
dc.description.abstract | Background : Plasmid-mediated AmpC β-lactamases (PABL) are cephalosporinases that conferresistance to a wide variety of β-lactam drugs and that may thereby create serious therapeutic problems. The PABL-producing organisms are a major concern in nosocomial infections and should therefore be monitored in surveillance studies. Although reported with increasing frequency in Korea, the occurence and genotypic distributions of PABL in Escherichia coli and Klebsiella pneumoniae remain unknown.
Methods : We tested a total of 911 consecutive, nonduplicate isolates of E, coli and K. pneumo-niae at 12 university hospitals and a commercial laboratory in Korea. Antimicrobial susceptibilities were tested using the disk diffusion method. PABL production was determined by the modified Hodge test and multiplex PCR. The PCR differentiated the six PABL-specific families in E, coji and K. pneumoniae Results : Overall,110 (12.1%) yielded cefoxitin non-susceptible isolates and that 28 (3.1%) demonstrated PABL producers by multiplex PCR. Based on the species, of 544E, coli and 367 K. pneumoniae isolates tested,8 (1.5%) and 20 (5.4%), respectively, demonstrated PABL producers. The genotypes of PCR amplification showed that the MOX, DHA, and CIT family were harbored by 4,2, and 2of 8 PABL-producing E coli´, and the DHA, MOX, and EBC family were harbored by 13,6, and 1 of 20PABL-producing K. pneumoniae isolates, respectively. Conclusions : These data confirm that the occurrence of PABL-producing E. coli and K. pneumoniae is relatively high and the kinds of genotypes are variously distributed in Korea. | en |
dc.description.abstract | 배경 : Plasmid성 AmpC -lactamase (PABL)는 -lac-tam제에 광범위하게 내성을 나타내어 환자의 치료에 심각한 문제를 초래할 수 있는 cephalosporinase이다. 따라서 PABL 생성균주는 병원감염의 주요 관심대상이 되고 있다. 세계적으로 이균주의 보고가 증가하고 있으나 한국의 경우 E. coli와 K. pneu-moniae에 대한 PABL 생성균주의 빈도와 유전자형의 분포는 아직 잘 모르고 있다.
방법 : 저자들은 한국의 12개 대학병원과 1개의 검사센타에서총 91주의 연속적이고 중복되지 않게 분리된 E. coli와 K.pneumoniae를 대상으로 디스크확산법으로 항균제감수성시험을시행하였다. 변법 Hodge 시험과 PABL 유전자형을 6 개군으로 분류하여 검출할 수 있는 multiplex PCR을 시행하여 PABL 생성여부를 검출하였다. 결과 : 총 110주(12.1%)가 cefoxitin에 비감수성이었고 이중28주(3.1%)가 multiplex PCR 검사상 PABL 생성균주이었다.균종별로는 54주의 E. coli와 367주의 K. pneumoniae 에서 각각8주(1.5%)와 20주(5.4%)가 PABL 생 성균주이었다. 8주의 E.coli에서는 MOX, DHA, CIT군 유전자형이 각 4, 2, 2주이었고 20주의 K. pneumoniae 에서는 DHA, MOX, EBC군 유전자형이 각각 13, 6, 1주이었다. | ko |
dc.format | text/plain | - |
dc.language.iso | ko | - |
dc.title | Occurrence and Genotypic Distributions of Plasmid-Mediated AmpC β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae in korea | en |
dc.title.alternative | 한국에서 분리된 Plasmid-Mediated AmpC β-Lactamase 생성 Escherichia coli와 Klebsiella pneumoniae의 빈도와 유전자형의 분포 | ko |
dc.type | Article | - |
dc.identifier.url | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001188892 | - |
dc.subject.keyword | Plasmid-Mediated AmpC β-Lactamase | - |
dc.subject.keyword | Escherichia coil | - |
dc.subject.keyword | Klebsiella pneumoniae | - |
dc.subject.keyword | Modified Hodge test | - |
dc.subject.keyword | Multiplex PCR | - |
dc.subject.keyword | Korea | - |
dc.contributor.affiliatedAuthor | 이, 위교 | - |
dc.type.local | Journal Papers | - |
dc.citation.title | Annals of laboratory medicine | - |
dc.citation.volume | 22 | - |
dc.citation.number | 6 | - |
dc.citation.date | 2002 | - |
dc.citation.startPage | 410 | - |
dc.citation.endPage | 416 | - |
dc.identifier.bibliographicCitation | Annals of laboratory medicine, 22(6). : 410-416, 2002 | - |
dc.identifier.eissn | 2234-3814 | - |
dc.relation.journalid | J022343806 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.